# Commission Regulation (EC) No 2032/2003 of 4 November 2003 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, and amending Regulation (EC) No 1896/2000 (Text with EEA relevance) (repealed)

EU Regulation No 2032/2003 · adopted 4 November 2003

Commission Regulation (EC) No 2032/2003 of 4 November 2003 on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, and amending Regulation (EC) No 1896/2000 (Text with EEA relevance) (repealed)

## Introductory text

Commission Regulation (EC) No 2032/2003
of 4 November 2003
on the second phase of the 10-year work programme referred to in Article 16(2) of Directive 98/8/EC of the European Parliament and of the Council concerning the placing of biocidal products on the market, and amending Regulation (EC) No 1896/2000
(Text with EEA relevance) (repealed)
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 1 Subject matter

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 2 Definitions

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 3 Existing Active Substances

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 4 Non-inclusion

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 4a Essential use

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 4b Extension of deadline for placing on the market

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 5 Review of notified existing active substances

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 6 Preparation of the complete dossier

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 7 Submission of the complete dossier

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 8 Joining, replacing or withdrawal of participants

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 9 Completeness check of dossiers

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 10 Evaluation of dossiers by the Rapporteur Member State

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 11 Commission procedures

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 12 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 13 Suspension of procedures

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 14 Amendments to Regulation (EC) No 1896/2000

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## 15 Entry into force

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Signature

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Annex I EXISTING ACTIVE SUBSTANCES

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Annex II EXISTING ACTIVE SUBSTANCES AND PRODUCT TYPES INCLUDED IN THE REVIEW PROGRAMME

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Annex III EXISTING ACTIVE SUBSTANCES THAT HAVE BEEN IDENTIFIED BUT IN RESPECT OF WHICH NO NOTIFICATION HAS BEEN ACCEPTED OR NO MEMBER STATE HAS INDICATED AN INTEREST AND EXISTING ACTIVE SUBSTANCES THAT HAD BEEN NOTIFIED BUT IN RESPECT OF WHICH NO DOSSIER WAS SUBMITTED OR ACCEPTED AS COMPLETE AND FOR WHICH NO PRODUCER, FORMULATOR, ASSOCIATION, OTHER PERSON OR MEMBER STATE HAS INDICATED AN INTEREST TO TAKE OVER THE ROLE OF PARTICIPANT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Annex IV: REQUIREMENTS FOR THE COMPLETE DOSSIER AND THE SUMMARY DOSSIER

## (a) 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## (b) The summary dossier must include the following:

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## (c) 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## (d) 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Annex V: TIME PERIODS AND RAPPORTEUR MEMBER STATES FOR THE SUBMISSION OF COMPLETE DOSSIERS FOR EXISTING ACTIVE SUBSTANCES INCLUDED IN THE REVIEW PROGRAMME

## A 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## B 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## C 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## D 

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Annex VI: COMPETENT AUTHORITIES, AS REFERRED TO IN ARTICLE 5(4) AS OF 1 MARCH 2005

## BELGIUM

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## CZECH REPUBLIC

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## DENMARK

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## GERMANY

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## ESTONIA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## GREECE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## SPAIN

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## FRANCE

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## IRELAND

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## ITALY

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## CYPRUS

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## LATVIA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## LITUANIA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## LUXEMBOURG

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## HUNGARY

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## MALTA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## NETHERLANDS

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## AUSTRIA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## POLAND

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## PORTUGAL

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## SLOVENIA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## SLOVAKIA

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## FINLAND

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## SWEDEN

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## UNITED KINGDOM

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## ICELAND

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## NORWAY

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Annex VII EXISTING ACTIVE SUBSTANCES THAT WERE NOT IDENTIFIED BY 28 MARCH 2002 BUT MAY REMAIN ON THE MARKET UNTIL 1 SEPTEMBER 2006

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

## Annex VIII EXISTING ACTIVE SUBSTANCES THAT WERE NOTIFIED BUT IN RESPECT OF WHICH NO DOSSIER WAS SUBMITTED OR ACCEPTED AS COMPLETE AND FOR WHICH ANOTHER PRODUCER, FORMULATOR, ASSOCIATION, OTHER PERSON OR MEMBER STATE HAS INDICATED AN INTEREST TO TAKE OVER THE ROLE OF PARTICIPANT

. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .

---
Source: https://www.legislation.gov.uk/eur/2003/2032 (the official version)
Page: https://openlegislation.uk/eu-regulation-2003-2032
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.